Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy: a Randomized, Double-blinded, Placebo-Controlled Trial

​ Conditions: IgA Nephropathy (IgAN)

Interventions: Drug: NEFECON; Drug: Placebo

Sponsors: Nanfang Hospital, Southern Medical University

Not yet recruiting Conditions: IgA Nephropathy (IgAN)
Interventions: Drug: NEFECON; Drug: Placebo
Sponsors: Nanfang Hospital, Southern Medical University
Not yet recruiting